ScreenerHero

DXB Dimerix Limited

ASX · AU · Healthcare · Biotechnology · dimerix.com
—Mkt Cap: —P/E: —

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease;…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value76.13M USD
Revenue (TTM)4.39M USD
Gross Profit3.01M USD
Net Income (TTM)-20.60M USD
Revenue/Share0.01 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees15
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000DXB7
Valuation
P/E (Trailing)—
P/E (Forward)-10.50
PEG0.72
EV/EBITDA-3.13
EV/Revenue17.34
P/S19.84
P/B-8.40
EPS (TTM)-0.05
EPS (Forward)-0.02
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-317.50%
EBITDA Margin0.00%
Profit Margin-685.32%
ROE202.03%
ROA-50.88%
Growth
Revenue Growth-20.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.80M USD
CapEx (TTM)3.44K USD
FCF Margin-762.61%
FCF Yield—
Net Debt-11.00M USD
Net Debt/EBITDA0.45
Balance Sheet
Debt/Equity-0.02
Current Ratio3.82
Quick Ratio3.75
Book Value/Sh-0.03 AUD
Cash/Share0.03 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 24, 1999
Pay Date—
Splits
Last Split1:20
Split DateOct 23, 2017
Analyst Consensus
Rating—
Target (Mean)1.895 AUD
Target Range1.895 AUD – 1.895 AUD
# Analysts1
Ownership
Shares Out.600.40M
Float463.94M
Insiders22.23%
Institutions3.02%
Technical
SMA 500.2597 AUD
SMA 2000.3129 AUD
Beta0.35
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)569.74K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—